Form 4 for ABBV AbbVie
Accepted 2022-02-08 00:00:00 ET · period of report 2022-02-07 · accession 0001179110-22-000922 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-08 | 2022-02-07 | ABBV | Strom Carrie C | SVP, Pres Gbl Allerg Aesth | A - Grant | $47.27 | +4,184 | 44.9K | +10% | +$197.8K |
| D | 2022-02-08 | 2022-02-07 | ABBV | Strom Carrie C | SVP, Pres Gbl Allerg Aesth | S - Sale | $141.17 | -2,396 | 42.5K | -5% | -$338.2K |
| D | 2022-02-08 | 2022-02-07 | ABBV | Strom Carrie C | SVP, Pres Gbl Allerg Aesth | M - OptEx | $0.00 | +4,184 | 0 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2022-02-07 | A | A | 4,184 | $47.27 | 44,895 | D | — | — | |
| 2 | Common | Common Stock, $0.01 par value | 2022-02-07 | S | D | 2,396 | $141.17 | 42,499 | D | — | — | |
| 3 | Derivative | Option (right to buy) | 2022-02-07 | M | A | 4,184 | $0.00 | 0 | D | $47.27 · 2013-02-17 to 2022-02-17 | 4,184 Common Stock | (F1) Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. |